United Kingdom· GB-APID-44682711000001101
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler
A medicinal product containing fluticasone + umeclidinium bromide + vilanterol, registered in United Kingdom by Pilsco Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fluticasone + Umeclidinium bromide + Vilanterol
- Manufacturer
- Pilsco Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluticasone + umeclidinium bromide + vilanterol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandElebrato ElliptaGlaxoSmithKline Trading Services Limited
- SpainELEBRATO ELLIPTA 92 MICROGRAMOS/55 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)Glaxosmithkline Trading Services Limited
- SwedenElebrato Ellipta 92 mikrogram/55 mikrogram/22 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- SwitzerlandTrelegy Ellipta, Einzeldosiertes Pulver zur InhalationGlaxoSmithKline AG
- PolandElebrato ElliptaGlaxoSmithKline Trading Services Limited
- CanadaTRELEGY ELLIPTAGLAXOSMITHKLINE INC
- IrelandTrelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline Trading Services Limited
- NorwayTrelegy ElliptaGlaxoSmithKline Trading Services Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elebrato Ellipta, Trelegy Ellipta
- Liechtenstein · Elebrato Ellipta, Trelegy Ellipta
- Norway · Elebrato Ellipta, Trelegy Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d85705a5-d11e-4fac-b7bd-7e2cbda2b4a9 GET /v1/drugs/d85705a5-d11e-4fac-b7bd-7e2cbda2b4a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44682711000001101",
"desc": "Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pilsco Ltd)",
"form": "Inhalation powder",
"vpid": "34955111000001103",
"source": "dmd",
"vtm_id": "34955711000001102",
"strength": "22 microgram",
"substance": "Fluticasone + Umeclidinium bromide + Vilanterol",
"ingredient": "Vilanterol trifenatate",
"supplier_code": "37621811000001104"
}See everything about fluticasone + umeclidinium bromide + vilanterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.